Blood Donation and Kidney Disease: What Dialysis Patients and Kidney Donors Need to Know

India has an estimated 17.2% prevalence of chronic kidney disease (CKD) — one of the highest in the world. Approximately 850,000 new patients reach end-stage kidney disease (ESKD) annually, with the vast majority unable to access renal replacement therapy due to cost and infrastructure.

For those who do access dialysis — an estimated 200,000+ patients on chronic haemodialysis in India — blood donation is not an abstract public health concern. It is a direct, personal dependency. Nearly all dialysis patients develop anaemia. Many require regular blood transfusions to keep haemoglobin at levels compatible with quality of life and physiological function.

At the same time, many people with kidney disease — including those who have donated a kidney — want to know whether they can still donate blood. The answers to both questions matter enormously to India's kidney disease community.

Why Dialysis Patients Need Blood

The Anaemia of Chronic Kidney Disease (CKD Anaemia)

Healthy kidneys produce erythropoietin (EPO) — the hormone that signals bone marrow to produce red blood cells. When kidneys fail, EPO production falls. Without adequate EPO, bone marrow slows red blood cell production, and haemoglobin drops progressively.

The result is normochromic normocytic anaemia — a type of anaemia directly caused by insufficient EPO, not iron deficiency or nutritional deficiency (though these can coexist and worsen the picture in CKD patients who have poor nutrition or blood losses from dialysis access).

In patients on haemodialysis:

• Blood loss occurs during each dialysis session — trapped in the dialysis circuit, in sampling tubes, and from access site bleeding
• Frequent blood tests further reduce haemoglobin
• The dialysis process itself can cause red blood cell fragility

Without treatment, dialysis patients can reach haemoglobin levels of 7–9 g/dL — well below the normal range of 12–16 g/dL. At these levels, patients experience severe fatigue, breathlessness, reduced cognitive function, and poor quality of life.

Treatment: EPO Injections and Blood Transfusion

The primary treatment for CKD anaemia is erythropoiesis-stimulating agents (ESAs) — synthetic EPO injections that stimulate red blood cell production. These are effective but expensive (costing tens of thousands of rupees monthly for many patients) and not universally accessible in India's public dialysis system.

When ESA treatment is insufficient, unavailable, or when haemoglobin drops rapidly due to bleeding or acute illness, blood transfusion is the bridge. A transfusion of packed red blood cells can rapidly raise haemoglobin to safe levels.

For dialysis patients in India who cannot afford or access ESA therapy consistently — a large proportion given the cost and infrastructure gaps — blood transfusions are more frequently needed than international guidelines recommend. In some government dialysis centres, blood transfusion dependency is significant.

Blood Demand from India's Kidney Disease Burden

India's national blood demand study attributed medical specialties to 6 million units — 41.2% of total blood demand. Within medicine, kidney disease (including dialysis anaemia, transplant-related blood needs, and acute kidney injury) is a significant contributor, though it is not separated as a standalone line item in published national data.

Kidney transplant blood demand is separately significant: a single kidney transplant may require 2–6 units of blood components during the operative and perioperative period, depending on surgical complexity and the patient's pre-operative haemoglobin status. India performs an estimated 10,000–15,000 kidney transplants annually — generating meaningful aggregate blood demand.

The Transfusion Sensitivity Problem in Transplant Patients

For patients awaiting kidney transplant, blood transfusions carry a specific concern that makes this population particularly challenging from a blood banking standpoint.

Alloimmunisation: When a transplant candidate receives blood transfusions, their immune system may develop antibodies against the donor's HLA (Human Leukocyte Antigen) antigens. These anti-HLA antibodies reduce the pool of compatible kidney donors — making transplantation more difficult or, in highly sensitised patients, nearly impossible.

This is why transplant nephrologists try to minimise transfusions in transplant candidates where possible, using ESAs and iron therapy to maintain haemoglobin without transfusion. When transfusion is unavoidable, leukoreduced blood (with white blood cells removed) is preferred to reduce the sensitisation risk.

The practical implication for blood donation: transplant programmes and dialysis units require leukoreduced packed red blood cells — a component that requires blood banks to have leukoreduction filters. Not all blood banks in India have this capability, creating an access gap for transplant candidates in smaller cities.

Can CKD or Dialysis Patients Donate Blood?

This question comes from two directions: people who have been diagnosed with CKD but are not yet on dialysis, and people who have donated a kidney and want to know if they can still donate blood.

Mild CKD (Stages 1–2) — Generally Eligible

Patients with early CKD (normal or mildly reduced kidney function, no significant anaemia, no uncontrolled blood pressure) are generally eligible to donate blood, provided they meet all standard criteria including haemoglobin ≥12.5 g/dL and blood pressure within normal range.

Many people with mild CKD live entirely normal lives and have normal haemoglobin — their kidney disease is a diagnosis, not a symptom. The haemoglobin check before every donation functions as a practical safety gate.

Moderate-Advanced CKD (Stages 3–5) — Usually Deferred

As CKD progresses and EPO deficiency begins reducing haemoglobin, most patients with Stage 3–5 CKD will be deferred for low haemoglobin at donation screening. This is not a permanent policy exclusion — it is a practical consequence of the haemoglobin threshold.

Patients on Haemodialysis — Generally Deferred

Active dialysis patients are generally deferred from blood donation. Reasons:

• Haemoglobin is typically too low to meet the donation threshold
• The physiological stress of blood volume loss is contraindicated in patients whose kidneys cannot regulate fluid balance
• Medications used in dialysis (anticoagulants, EPO, iron injections) may affect donation eligibility

Living Kidney Donors — Generally Eligible After Recovery

People who have donated one kidney can donate blood — one kidney is sufficient for normal physiological function including blood production. The deferral period after nephrectomy (kidney donation surgery) is typically 6 months to allow full surgical recovery, after which eligible kidney donors who meet all standard criteria (haemoglobin, blood pressure, general health) can donate blood.

This is an important message for India's living kidney donor community. Having given a kidney does not close the door to blood donation — it may simply push the timeline out by six months.

The Role of TheBloodApp for Kidney Patients and Families

For families managing kidney disease — whether a relative on dialysis, a transplant candidate, or a post-transplant patient — TheBloodApp serves as the fastest way to find compatible blood urgently.

Dialysis-related emergencies — a patient whose haemoglobin crashes before their next ESA cycle, a transplant patient bleeding post-operatively — require rapid blood access that hospital blood banks may not always have in stock. A registered network of voluntary donors reachable within minutes is the most effective emergency backup.

If your family member is on dialysis or has had a kidney transplant, register on TheBloodApp now — before an emergency — with their blood type. When blood is needed urgently, you will have a head start.

Register on TheBloodApp. If you are healthy and have mild kidney disease, talk to your doctor about blood donation eligibility. If you have donated a kidney and are past your surgical recovery, you may be eligible to donate blood — and your altruistic record suggests you are exactly the person the system needs. To find blood banks and urgent donation in your city, call the number listed in the app.

Sources: PMC — CKD India Prevalence | PMC — National Blood Demand Study India | FOGSI — Blood Transfusion Guidelines | NBTC India — Donor Deferral Guidelines | WHO — Kidney Disease Anaemia | Apollo Hospitals — Anaemia CKD | eRaktKosh MoHFW | Indian Society of Nephrology